Alaunos Therapeutics Inc (TCRT)
2.39
+0.07
(+3.02%)
USD |
NASDAQ |
Nov 22, 16:00
2.355
-0.04
(-1.46%)
After-Hours: 20:00
Alaunos Therapeutics Cash from Operations (Quarterly): -0.781M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -0.781M |
| June 30, 2024 | -1.681M |
| March 31, 2024 | -1.917M |
| December 31, 2023 | -7.385M |
| September 30, 2023 | -6.374M |
| June 30, 2023 | -7.002M |
| March 31, 2023 | -9.381M |
| December 31, 2022 | -7.13M |
| September 30, 2022 | -6.145M |
| June 30, 2022 | -8.187M |
| March 31, 2022 | -7.77M |
| December 31, 2021 | -15.13M |
| September 30, 2021 | -9.577M |
| June 30, 2021 | -21.45M |
| March 31, 2021 | -15.31M |
| December 31, 2020 | -17.04M |
| September 30, 2020 | -16.06M |
| June 30, 2020 | -14.01M |
| March 31, 2020 | -9.906M |
| December 31, 2019 | -11.61M |
| September 30, 2019 | -10.93M |
| June 30, 2019 | -8.087M |
| March 31, 2019 | -10.23M |
| December 31, 2018 | -11.82M |
| September 30, 2018 | -8.507M |
| Date | Value |
|---|---|
| June 30, 2018 | -10.17M |
| March 31, 2018 | -18.96M |
| December 31, 2017 | -12.16M |
| September 30, 2017 | -12.71M |
| June 30, 2017 | -15.52M |
| March 31, 2017 | -14.28M |
| December 31, 2016 | -13.06M |
| September 30, 2016 | -14.11M |
| June 30, 2016 | -15.07M |
| March 31, 2016 | -16.08M |
| December 31, 2015 | -23.80M |
| September 30, 2015 | 45.20M |
| June 30, 2015 | -11.69M |
| March 31, 2015 | -9.717M |
| December 31, 2014 | -9.87M |
| September 30, 2014 | -10.49M |
| June 30, 2014 | -7.635M |
| March 31, 2014 | -8.654M |
| December 31, 2013 | -9.045M |
| September 30, 2013 | -15.50M |
| June 30, 2013 | -16.72M |
| March 31, 2013 | -18.24M |
| December 31, 2012 | -21.50M |
| September 30, 2012 | -14.71M |
| June 30, 2012 | -16.76M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-21.45M
Minimum
Jun 2021
-0.781M
Maximum
Sep 2024
-9.692M
Average
-8.784M
Median
Cash from Operations (Quarterly) Benchmarks
| Microbot Medical Inc | -2.759M |
| SELLAS Life Sciences Group Inc | -7.806M |
| Galectin Therapeutics Inc | -8.538M |
| Oragenics Inc | -1.970M |
| Anavex Life Sciences Corp | -5.18M |
Cash from Operations (Quarterly) Related Metrics
| Free Cash Flow | -11.76M |
| Free Cash Flow Per Share (Quarterly) | -0.4877 |
| Free Cash Flow Yield | -307.4% |